Literature DB >> 11896648

The organization of letter-form representations in written spelling: evidence from acquired dysgraphia.

Michele Miozzo1, Pierluigi De Bastiani.   

Abstract

We report on an Italian brain-damaged patient with impaired written spelling. The patient's errors, in different fonts and scripts, consist mainly of letter substitutions (e.g., filo [thread] --> TILO). The results of various tests indicate that letter substitution errors arise because of a deficit in accessing the letter-form representations supporting written spelling. Letter substitutions occurred predominantly between letters with common strokes (e.g., C and G; b and p). Similarities in terms of global letter shape or letter sound were not valid predictors of letter substitution errors. Letter frequency, consonant-vowel status, and letter gemination were factors affecting letter substitution errors. The results of our investigation suggest that information about letter strokes are stored at the level of letter-form representations, and that access to these representations is sensitive to letter frequency. The results further indicate that letter-form representations do not specify whether a letter is a consonant or a vowel, or is a geminate. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Year:  2002        PMID: 11896648     DOI: 10.1006/brln.2001.2598

Source DB:  PubMed          Journal:  Brain Lang        ISSN: 0093-934X            Impact factor:   2.381


  3 in total

Review 1.  Alphabetic letter identification: effects of perceivability, similarity, and bias.

Authors:  Shane T Mueller; Christoph T Weidemann
Journal:  Acta Psychol (Amst)       Date:  2011-10-26

2.  Relationships between Presence or Absence of ADHD and fMRI Connectivity Writing Tasks in Children with Dysgraphia.

Authors:  Todd Richards; Robert D Abbott; Virginia W Berninger
Journal:  J Nat Sci       Date:  2016

3.  Developmental dysgraphia: An overview and framework for research.

Authors:  Michael McCloskey; Brenda Rapp
Journal:  Cogn Neuropsychol       Date:  2017-09-14       Impact factor: 2.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.